CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1 - 10 of 826
Study Number Lead Group Study Title CIRB Study Status
URCC-18004CD NCORP-University of Rochester Cancer Center Understanding the Impact of Drug Shortages on Oncology Care Delivery Cancer Prevention and Control CIRB Completed
EA1151 ECOG-ACRIN Tomosynthesis Mammographic Imaging Screening Trial (TMIST) Cancer Prevention and Control CIRB Available to Open
S1600 SWOG A Randomized Phase III Double-Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes Cancer Prevention and Control CIRB Available to Open
ECOG-EA9131 ECOG-ACRIN A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) Cancer Prevention and Control CIRB Available to Open
MAY2016-08-01 CLO-Mayo Clinic A Pilot Study of MUC1 Vaccine in Current and Former Smokers at High Risk for Lung Cancer Cancer Prevention and Control CIRB Available to Open
WF-30917CD NCORP-Wake Forest University A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors Cancer Prevention and Control CIRB Available to Open
A221405 Alliance A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer who Desire Pregnancy Cancer Prevention and Control CIRB Available to Open
A171601 Alliance A phase II trial assessing the tolerability of palbociclib in combination with letrozole or fulvestrant in patients aged 70 and older with estrogen receptor-positive, HER2-negative metastatic breast cancer Cancer Prevention and Control CIRB Available to Open
NRG-CC008 NRG A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk] Cancer Prevention and Control CIRB Available to Open
MDA2014-04-01 CLO-MD Anderson Alternative Dosing of Exemestane in Postmenopausal Women with Stage 0-II ER-Positive Breast Cancer: a Randomized Presurgical Trial Cancer Prevention and Control CIRB Available to Open
Displaying 1 - 10 of 826